A research team develop biotransistors able to hear small beats of live Blog Post

Researchers at the Institute for Bioengineering of Catalonia (IBEC) in the Barcelona Science Park, in collaboration with the Institute of Materials Science of Barcelona (ICMAB-CSIC), develop a flexible, cheap and biocompatible transistor platform able to record an electrocardiogram of cells and micro-tissues during long periods of time.The platform, based on organic transistor technology (EGOFET), can also measure the effect of drugs on beating cells, as cardiomyocytes, opening the door to several applications such as implantable devices for health.

 

TMB Foundation colaborates with Aromics to combat the effects of health arising from asbestos Blog Post

TMB Foundation developed over the coming weeks various activities to raise awareness of the harmful effects of asbestos exposure to human health, in collaboration with the biotech company Aromics Biotech –based in the Barcelona Science Park– and other specialized organizations. This has been the cause of social chosen by company employees, who every year are the protagonists, with their proposals and its vote of solidarity program Choose your cause.

 

A smartphone for detecting sleep apnea at home Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park (PCB) has developed a portable, cheap and non-invasive system to detect Obstructive Sleep Apnea (OSA) at home, a disorder characterized by recurrent airflow cessation during sleep. Researchers propose a novel method consisting of analyzing acoustic signals recorded with a smartphone.

 

IRB Barcelona researcher Roger Gomis receives a grant from Fundación Fero Blog Post

The Fundación Fero, an organisation devoted to furthering cancer research, with the collaboration of Mango, has awarded Roger Gomis, ICREA researcher at the Institute for Research in Biomedicine (IRB Barcelona) in the Barcelona Science Park, funding for his project addresses the development of breast cancer metastasis. The grants were presented last night in one of two yearly charity events organised by the foundation in Madrid and, once again.

 

The European biotechnology sector to meet in Hamburg Blog Post

Hamburg will host this year, from November 11 to 13, the 25th edition of BIO-Europe, the most important partnering event for the biotechnology and pharmaceutical industry in Europe, organized by EBD-Group. Biocat, the organization that coordinates and promotes the healthcare and life sciences sector in Catalonia, from its headquarters in the Barcelona Science Park (PCB), will be at the fair and help raise awareness of Catalan presence internationally. The event will feature, once again, an outstanding representation of the PCB Community.

 

Researchers from CNAG, IBEC and IRB Barcelona receive funding from La Marató 2018 Blog Post

Yesterday, the Fundació La Marató de TV3 announced the research teams of excellence that will receive funding thanks to 15 million euros, a record amount, collected in the last edition of the program, for cancer research. Collaborative projects involving researchers from three centres located in the Barcelona Science Park (PCB) are among the winners, namely the Centro Nacional de Análisis Genómico (CNAG-CRG), the Institute for Bioengineering of Catalonia (IBEC) and the Institute for Research in Biomedicine (IRB Barcelona). 

 

Home stroke recovery thanks to virtual reality Blog Post

Today is the World Stroke Day, a medical condition that affects to 14.5 million people every year and it is the leading cause of death in women and the second cause in men. Health innovation contributes speeding up recovery of patients and it drastically reduces the number of visits to clinic as well as the duration of treatment in hospitals and therapy centres. It also reduces costs at the health public system. In these cases, technology can be a powerful ally, as can be seen from EIT Health Innovation Projects. EIT Health Spain, the Spanish Co-Location Center (CLC) of EIT Health, is headquartered at the Barcelona Science Park.

 

GlyCardial begins the clinical trial of its novel diagnostic device for myocardial ischemia Blog Post

GlyCardial Diagnostics, located at the Barcelona Science Park, has announced the enrolment of the first two patients in the EDICA trial: a multicenter international clinical study for the early detection of myocardial ischaemia. The company –a spinoff of the Research Institute of the Hospital de la Santa Creu i Sant Pau (IR-HSCSP) and the Spanish National Research Council (CSIC), has developed innovative technology for the detection of Apo J-Glyc protein, as a novel biomarker in blood for the diagnosis and prognosis of myocardial ischemia, and expects to demonstrate the reliability of the new test in hospital laboratories.